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BACKGROUND OF THE 2020 GUIDELINES FOR ADULT ADVANCED 
LIFE SUPPORT
Adult advanced life support (ALS) is an important part of the chain of survival, promoting sys-
temic circulation and oxygen supply during high-quality basic life support in patients with car-
diac arrest. It includes advanced airway management, manual defibrillation, pharmacological 
therapy with vasopressors and antiarrhythmic agents, use of an extracorporeal circulation de-
vice, and other techniques to achieve return of spontaneous circulation (ROSC).1-3
 Several milestone studies on ALS have been published since the publication of the 2015 Kore-
an cardiopulmonary resuscitation (CPR) guidelines. These include a multicenter, randomized, dou-
ble-blind, placebo-controlled study evaluating the effect of epinephrine in patients with out-of-
hospital cardiac arrest (OHCA) as well as a comparative study on amiodarone, lidocaine, or pla-
cebo in patients with refractory shockable rhythm.4,5 A study comparing the use of a supraglottic 
airway (SGA) device and endotracheal intubation for advanced airway management during OHCA 
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has also been published.6
 Based on new research evidence, relevant contents of the 2015 
CPR guidelines were revised in the 2020 Korean Adult ALS guide-
lines, with the addition of recommendations such as double se-
quential defibrillation, application of ultrasound, and monitoring 
of cerebral oxygen saturation during CPR.7-12 In particular, the es-
tablishment of a rapid response team (RRT) or medical emergency 
team and the application of an early warning score were empha-
sized for preventing in-hospital cardiac arrest (IHCA).13-19 Special-
ized guidelines for the resuscitation of patients with confirmed or 
suspected coronavirus disease 2019 (COVID-19) have also been 
included.20,21
ADULT ALS ALGORITHMS
High-quality CPR should be performed during all processes of 
ALS. The defibrillation pads or electrodes should be applied to the 
patient to monitor the electrocardiography (ECG) rhythm imme-
Fig. 1. Adult advanced life support algorithm for in-hospital cardiac arrest. CPR, cardiopulmonary resuscitation; VF, ventricular fibrillation; pVT, pulseless 
ventricular tachycardia; IV, intravenous; IO, intraosseous; PEA, pulseless electrical activity; 5H, hypovolemia, hypoxia, hyperkalemia, hydrogen ion (acido-
sis), and hypothermia; 5T, tension pneumothorax, tamponade (cardiac), toxin, thrombosis (pulmonary), and thrombosis (coronary); POCUS, point-of-care 
ultrasound; eCPR, extracorporeal cardiopulmonary resuscitation; ROSC, return of spontaneous circulation.
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diately after the ALS team arrives. Based on the ECG rhythm anal-
ysis, a team leader should decide on a treatment strategy as soon 
as possible. All team members should be proficient in the entire 
ALS algorithm so that it can be performed efficiently.
Adult ALS for IHCA 
When an ALS team arrives at the scene, the defibrillation pads or 
electrodes should be attached to the patient to analyze the ECG 
rhythm immediately. To ensure high-quality CPR, newly arrived 
providers should perform chest compressions and ventilation in 
place of basic life support (BLS) providers. The chest compression-
to-ventilation ratio should be 30:2 on 100% oxygen if an ad-
vanced airway has not been placed. Cardiac arrest rhythms are 
classified as shockable rhythms (ventricular fibrillation [VF] and 
pulseless ventricular tachycardia [pVT]) and non-shockable rhythms 
(asystole and pulseless electrical activity [PEA]). If the cardiac 
rhythm shows as a pVT or PEA, ALS providers should palpate the 
carotid artery to confirm the absence of a pulse. Since the ECG 
rhythm might change during CPR, providers should analyze it ev-
ery 2 minutes and follow the treatment algorithm according to 
the analysis (Fig. 1).
Shockable rhythms (VF and pVT)
Because VF and pVT can be terminated with defibrillation, they 
are also known as “shockable rhythms.” Providers should deliver a 
single shock (biphasic wave defibrillator: 120–200 J, monophasic 
wave defibrillator: 360 J) when a shockable rhythm is confirmed 
on the ECG monitor and resume CPR immediately for 2 minutes, 
beginning with chest compressions without a pulse check or ECG 
rhythm analysis. If the provider cannot identify the manufactur-
er’s recommended dose of the biphasic defibrillator, defibrillation 
(shock) should be conducted at 200 J. After the first shock is de-
livered, an intravenous (IV) or intraosseous (IO) route for drug ad-
ministration should be established, and a 1 mg bolus of epineph-
rine should be administered, followed by a bolus of IV fluids. The 
IO route should be attempted only if the IV access is unsuccessful 
or not feasible. Administration of 1 mg epinephrine should be re-
peated every 3 to 5 minutes while ALS continues. After 2 minutes 
of CPR, the ECG rhythm should be checked. If a shockable rhythm 
persists, the provider should deliver another shock with equiva-
lent or higher energy than the previous defibrillation and resume 
CPR immediately.
 Meanwhile, another provider should consider performing ad-
vanced airway management and capnography. If an advanced 
airway is in place, it is reasonable to deliver 1 breath every 6 sec-
onds (10 times/min) with continuous chest compressions. If en-
dotracheal intubation has been performed, monitoring of the 
end-tidal carbon dioxide (ETCO2) can assess the CPR quality and 
detect ROSC. If a shockable rhythm persists after 2 minutes of 
CPR, the provider should deliver another shock and resume CPR. 
Amiodarone or lidocaine can be prepared for refractory VF or pVT 
that is unresponsive to the second shock and may be adminis-
tered immediately after the third shock. The recommended first 
dose is 300 mg for amiodarone or 1 to 1.5 mg/kg for lidocaine. If 
the VF or pVT persists, a second dose of amiodarone 150 mg or li-
docaine 0.5 to 0.75 mg/kg can be administered. Based on the pa-
tient’s cardiac arrest situation or medical history, immediate iden-
tification and treatment of the reversible causes of cardiac arrest 
may facilitate ROSC. Point-of-care ultrasound (POCUS), if avail-
able and not interfering with CPR, may be helpful to identify the 
cause of cardiac arrest. Extracorporeal CPR (eCPR) may be con-
sidered if ROSC is not achieved despite a high-quality CPR and if 
there is a potentially reversible cause of cardiac arrest that might 
benefit from temporary cardiorespiratory support.
Non-shockable rhythms (asystole and PEA)
As asystole and PEA do not require defibrillation during CPR, they 
are referred to as “non-shockable rhythms.” Asystole is the ab-
sence of ventricular contraction regardless of the presence of 
atrial contraction. Meanwhile, PEA is a clinical condition defined 
by the absence of measurable blood pressure and palpable pulse 
despite the presence of sufficient electrical discharge and a het-
erogeneous group of pulseless rhythms, including pseudo-elec-
tromechanical dissociation, idioventricular rhythms, ventricular 
escape rhythms, and brady-asystolic rhythms. Patients with car-
diac arrest with PEA can be treated if the reversible causes are 
identified and corrected, even though the survival rate of cardiac 
arrest patients with asystole is very low. If the ECG rhythm is non-
shockable, chest compressions should be performed immediately 
for 2 minutes while the route (IV or IO) for drug administration is 
being established. Subsequently, a 1 mg bolus of epinephrine 
should be administered as soon as possible, along with an IV fluid 
push. Administration of 1 mg of epinephrine should be repeated 
every 3 to 5 minutes while ALS continues. After 2 minutes of CPR, 
the ECG rhythm should be analyzed. If the asystole or PEA per-
sists, chest compressions should be continued, and advanced air-
way management should be performed. If a shockable rhythm is 
observed, the shock should be delivered according to the “shock-
able rhythm” algorithm. POCUS, if available and not interfering 
with CPR, can be helpful to identify the cause of cardiac arrest.
Adult ALS for OHCA 
The adult ALS algorithm for OHCA is similar to that for IHCA. How-
ever, in OHCA, bag-mask ventilation (BMV) is preferably recom-
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Fig. 2. Adult advanced life support algorithm for out-of-hospital cardiac arrest. CPR, cardiopulmonary resuscitation; VF, ventricular fibrillation; pVT, 
pulseless ventricular tachycardia; PEA, pulseless electrical activity; IV, intravenous; IO, intraosseous; 5H, hypovolemia, hypoxia, hyperkalemia, hydrogen 
ion (acidosis), and hypothermia; 5T, tension pneumothorax, tamponade (cardiac), toxin, thrombosis (pulmonary), and thrombosis (coronary); ROSC, return 
of spontaneous circulation.
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mended for providers who are unfamiliar with advanced airway 
management. Using an SGA device is also preferred to endotra-
cheal intubation for providers with little experience in endotra-
cheal intubation. It is recommended to consider transferring the 
patient to the hospital after performing ALS on scene for 10 min-
utes if the emergency medical technicians (EMTs) participating in 
the resuscitation could perform ALS, including advanced airway 
management and epinephrine administration. In contrast, it is 
recommended to transfer the patient to the hospital after resus-
citation for 6 minutes according to the BLS guidelines if the pre-
hospital resuscitation team could not perform ALS. For example, 
in the case of a multitiered dispatch system, if the first EMT who 
arrives at the scene can perform ALS, the EMT should consider 
transferring the patient to the hospital after providing ALS for 10 
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Fig. 3. Adult advanced life support for cardiac arrest during the COVID-19 outbreak. PPE, personal protective equipment; CPR, cardiopulmonary resusci-
tation; VF, ventricular fibrillation; pVT, pulseless ventricular tachycardia; PEA, pulseless electrical activity; IV, intravenous; IO, intraosseous; 5H, hypovole-
mia, hypoxia, hyperkalemia, hydrogen ion (acidosis), and hypothermia; 5T, tension pneumothorax, tamponade (cardiac), toxin, thrombosis (pulmonary), 
and thrombosis (coronary); POCUS, point-of-care ultrasound; eCPR, extracorporeal cardiopulmonary resuscitation; ROSC, return of spontaneous circula-
tion.
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minutes; otherwise, providing 6 minutes of CPR and then trans-
ferring the patient to the hospital would be appropriate. Scene 
time interval could be modified under direct medical oversight 
(Fig. 2).
Adult ALS for cardiac arrest during the COVID-19  
outbreak 
Chest compressions, positive pressure ventilation, and securing an 
advanced airway can generate aerosols, which could increase the 
risk of transmission of COVID-19. It is essential that providers 
protect themselves and their colleagues from unnecessary expo-
sure to both airborne and droplet particles. Members of the ALS 
team should wear appropriate personal protective equipment 
(PPE) with a minimum of Level D protection, including a mask (a 
minimum of N95 or FFP3) or powered air-purifying respirator, 
gloves, gown, and goggles or face shield before starting ALS. For 
patients with a poor prognosis, the provision of resuscitation 
should be reevaluated, and ALS should be started when resuscita-
tion is deemed necessary. The ALS team should comprise the mini-
mum number of essential personnel. A mechanical CPR device 
can be used to minimize contact with the patient. For ECG 
rhythm check and defibrillation, a defibrillation pad should be 
used, if feasible. If advanced airway management is required, the 
provider should stop the chest compressions, perform endotra-
cheal intubation with a cuffed tube, and connect the endotra-
cheal tube with a high-efficiency particulate air filter, if available. 
Video laryngoscopy for endotracheal intubation should also be 
considered to reduce exposure to aerosol. If endotracheal intuba-
tion is delayed, the provider should consider attaching an SGA de-
vice or bag-valve mask to a high-efficiency particulate air filter 
with a tight seal. After completion of resuscitation, PPE should be 
disposed of according to the infection control guidelines and ALS 
providers should wash their hands thoroughly with soap and wa-
ter or disinfect them with alcohol-based hand sanitizer as soon 
as possible, followed by a change of clothes (Fig. 3).
RECOMMENDATIONS FOR ADULT ALS
Feedback device and monitoring during ALS
Using a feedback device and monitoring the patient can help op-
timize CPR quality and assess patient status during CPR.22 How-
ever, it is not recommended to implement real time CPR feedback 
devices routinely because their use has no significant effect on 
resuscitation outcome compared with not using them at all.23-26 
Nevertheless, real time CPR feedback devices in medical systems 
can be used for monitoring CPR quality. No studies have proven 
the usefulness of checking the pulse to evaluate the effectiveness 
of chest compressions during CPR. However, the pulse can be 
checked as a method to confirm ROSC. Providers should check 
the pulse within 5 to 10 seconds to minimize chest compression 
interruption and, if there is no pulse, resume chest compressions 
immediately.27-29 Advanced monitoring parameters such as ETCO2 
partial pressure, coronary perfusion pressure, and central venous 
oxygen saturation can be used as physiological monitoring indi-
ces during ALS. During cardiac arrest, ETCO2 levels reflect the car-
diac output generated by chest compressions. An ETCO2 level of 
<10 mmHg despite high-quality CPR of >20 minutes has been 
associated with an extremely poor chance of ROSC and survival 
outcome. An abrupt increase of ETCO2 during resuscitation may 
imply ROSC.30-34 However, ETCO2 partial pressure should not be 
used as a sole indicator of CPR quality and ROSC.
 Measuring the ETCO2 level from an SGA or bag-valve-mask 
airway cannot adequately predict the efficiency of chest com-
pressions and resuscitation outcomes, but it is the most reliable 
method for confirming the correct placement of an endotracheal 
tube after intubation.35 If the coronary perfusion pressure is <15 
mmHg during CPR, the chance of ROSC is low.36 However, coro-
nary perfusion pressure is difficult to monitor because it is calcu-
lated from the arterial relaxation “diastolic” pressure and central 
venous pressure during CPR. If the central venous oxygen satura-
tion (ScvO2) has been monitored prior to cardiac arrest, or if cath-
eterization is possible without interfering with resuscitation, pro-
viders can consider measuring the ScvO2 to monitor CPR quality. 
Studies have shown that a ScvO2 of <30% during CPR is associ-
ated with failure to restore spontaneous circulation; thus, provid-
ers should ensure high-quality CPR to maintain the ScvO2 above 
30%.37
 Pulse oximetry is not a suitable monitoring method because 
peripheral circulation is insufficient during cardiac arrest. Never-
theless, it can be used to evaluate proper oxygenation after 
ROSC.27 Moreover, regional cerebral oxygen saturation monitor-
ing using near-infrared spectroscopy during adult CPR can be 
easily applied noninvasively to help assess cerebral perfusion sta-
tus and predict ROSC and prognosis.11,38
Vascular access for drug administration in cardiac arrest
When performing high-quality CPR and defibrillation, providers 
should be able to establish a route for drug administration. This 
procedure should not interfere with chest compressions.39,40 The 
peripheral IV route is the traditional approach; it is reasonable 
that providers should first attempt IV access for drug administra-
tion during CPR.41,42 A fluid bolus of 20 mL should be injected af-
ter drug administration to promote the entry of drugs into the 
central circulation. Lifting the arm during or after drug injection 
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might theoretically promote the inflow of drug into the central 
circulation by gravity, although there is no evidence to support 
this. IO access, on the other hand, is safe and useful for infusion 
of fluids, administration of drugs, and blood sampling in patients 
of any age. However, two studies have shown that the rates of 
ROSC and survival to hospital discharge were lower with using IO 
access than with using IV access during cardiac arrest.40,43 IO ac-
cess may nonetheless be considered if IV access is unsuccessful 
or not feasible. Another option is drug administration via a cen-
tral venous catheter, which can achieve higher peak concentra-
tions and more rapid circulation than peripheral IV administra-
tion.44-46 Such a route may be considered by skilled providers 
when IV and IO access are unsuccessful or not feasible, although 
it may require interruption of CPR. An endotracheal tube may 
also be used, but drug delivery and pharmacological effects can 
be unpredictable with this route.47,48
Medications during cardiac arrest
Vasopressors
The alpha-adrenergic effect of epinephrine increases coronary ar-
tery perfusion pressure and cerebral perfusion pressure during 
CPR. In a study comparing the effects of epinephrine and placebo 
in patients with OHCA, the 3-month survival rate was higher in 
the group administered 1 mg of epinephrine at intervals of 3 to 5 
minutes.4 Therefore, it is recommended to administer 1 mg of 
epinephrine at intervals of 3 to 5 minutes to patients with cardi-
ac arrest regardless of the cardiac arrest rhythm. Other studies 
with a very low level of evidence showed that high-dose epineph-
rine administration improved spontaneous circulation and surviv-
al to hospital admission compared with standard-dose adminis-
tration (1 mg every 3 to 5 minutes in the form of a 1:1,000 am-
pule or 1:10,000 prefilled syringe formula) but did not improve 
survival to hospital discharge and neurological outcomes.49,50 There-
fore, routine administration of high doses of epinephrine is not 
recommended; however, an expert may deem it necessary.51
 The non-adrenergic peripheral vasoconstrictor, vasopressin, can 
also augment arterial blood pressure. A study comparing the ef-
fects of epinephrine and vasopressin found no difference in prog-
nosis in patients with OHCA.52,53 No differences were also found 
in the resuscitation outcomes in trials comparing vasopressin 
alone or vasopressin combined with epinephrine to epinephrine 
alone in cardiac arrest patients.54,55 However, no studies have 
shown that the use of vasopressin alone or in combination with 
epinephrine worsens the prognosis of cardiac arrest patients.52-56 
Therefore, 40 units of vasopressin or vasopressin in combination 
with epinephrine may be administered as an alternative for the 
first or second dose of epinephrine.
Antiarrhythmic drugs
Administration of amiodarone or lidocaine to OHCA patients with 
refractory VF or pVT improved survival to hospital admission but 
did not improve overall survival to hospital discharge or survival 
with good neurological outcome. The critical outcome of survival 
to hospital discharge was improved with amiodarone or lidocaine 
compared to placebo in patients with bystander-witnessed cardiac 
arrest; however, there was no difference between amiodarone and 
lidocaine with regard to ROSC, favorable neurological outcome, or 
survival to hospital discharge.5 Additionally, the routine use of 
magnesium is not recommended in adult cardiac arrest patients.57 
When using amiodarone, the first dose is 300 mg IV or IO, and 150 
mg can be added if the patient remains unresponsive. The first 
dose of lidocaine is 1 to 1.5 mg/kg IV or IO bolus, and then 0.5 to 
0.75 mg/kg every 5 to 10 minutes; up to 3 mg/kg can be add-
ed.57,58 Although lidocaine or beta-blockers may be considered for 
the prevention of arrhythmias immediately after ROSC in patients 
with refractory VF or pVT, their effectiveness remains uncertain.59,60
Defibrillation
Early defibrillation is crucial in patients with VF or pVT. Therefore, 
providers should deliver a shock immediately when the defibrilla-
tor is ready and a shockable rhythm is detected on ECG.61-65 Bi-
phasic waveform defibrillators are preferred over monophasic de-
fibrillators because they are more safe and effective.66,67 In un-
monitored cardiac arrest, a single-shock strategy is suggested be-
cause the success rate of the first shock is around 90% and chest 
compression interruption is prolonged in stacked shocks.68,69 
Chest compressions should be performed even while the defibril-
lator is charging. The chest compression interruption before and 
after defibrillation should be within 10 s during the entire process 
of resuscitation.70-73 For effective defibrillation, the shock should 
be delivered at the end of expiration to decrease transthoracic 
resistance, and it would be better to use defibrillation pads rather 
than paddles to ensure contact with the chest pads.74-76 The use-
fulness of double sequential defibrillation for refractory VF or pVT 
has not been established.9,77
Advanced airway management for resuscitation
Providers may use either BMV or an advanced airway strategy 
during ALS. However, in the case of advanced airway management 
in OHCA, EMTs without adequate training and experience in en-
dotracheal intubation should use an SGA device. It is recom-
mended that only experienced EMTs should try to perform endo-
tracheal intubation.78-83 For adult patients with IHCA, either an 
SGA device or endotracheal intubation may be considered.
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Use of mechanical chest compression devices
The use of mechanical chest compression devices has not shown 
improvement in the critical outcomes in OHCA and IHCA.84-90 How-
ever, the use of these devices may be considered in specific set-
tings where high quality manual compressions are not possible or 
may harm the providers (e.g., limited personnel, in a moving am-
bulance, during coronary angiography, during prolonged CPR, 
during eCPR, or risk of exposure to infectious disease such as CO-
VID-19).20,91
eCPR
eCPR refers to venoarterial extracorporeal membrane oxygen-
ation and cardiopulmonary bypass during the resuscitation of a 
cardiac arrest patient. Providers can consider applying eCPR to 
patients who have not achieved spontaneous circulation or have 
experienced repeated cardiac arrests despite receiving high quali-
ty CPR and patients who are expected to have a good neurologi-
cal outcome. Highly trained medical staff and proper equipments 
and facilities are necessary for successful application of extracor-
poreal membrane oxygenation.92,93 eCPR is recommended in pa-
tients aged <75 years and those with an initially shockable rhythm, 
a cardiac etiology or reversible cause of cardiac arrest, a no-flow 
time of <5 minutes, an unsuccessful resuscitation despite receiv-
ing ALS for >10 minutes, and a total collapse time of <60 min-
utes.94-107
ADDITIONAL CONSIDERATIONS DURING ALS
Proper oxygen and carbon dioxide targets during CPR 
and after ROSC
Based on previous CPR guidelines suggesting that a high oxygen 
level must be supplied during CPR and a study finding that the 
arterial partial pressure of oxygen was higher in resuscitated pa-
tients, it is recommended to supply 100% oxygen during CPR.108 
However, after ROSC, it is necessary to adjust the level of inhaled 
oxygen to maintain an oxygen saturation of 94% to 98%.109-111 
There is insufficient evidence for or against targeting mild hyper-
capnia compared with normocapnia in postcardiac arrest pati-
ents.109,110
Factors for predicting outcomes during CPR
Since the ETCO2 level reflects the cardiac output generated by 
chest compressions, it could be used to predict the patient’s out-
come during CPR. In intubated patients, ETCO2 levels of <10 mmHg 
after 20 minutes of ALS were associated with poor outcomes, 
which can be a factor for deciding on whether to terminate re-
suscitation.32,112 However, this parameter should not be used alone 
as a prediction tool for terminating resuscitation during CPR and 
should not be applied to patients who have not undergone endo-
tracheal intubation.
Application of ultrasonography during CPR
Experienced physicians can use an ultrasound, if it does not in-
terfere with CPR, to diagnose reversible causes of cardiac arrest 
such as cardiac tamponade, pulmonary thromboembolism (PTE), 
and myocardial infarction as well as to identify the existence of 
cardiac motility in patients with a PEA rhythm.10,113-115 Ultrasound 
can also be used as an alternative to ETCO2 capnography to con-
firm the correct placement of an endotracheal tube during CPR.116 
However, it should not be recommended as an independent pre-
dictor for terminating resuscitation.
PTE
Cardiac arrest due to PTE is the most dangerous complication of 
venous thromboembolism, and most cases of PTE are caused by 
deep vein thrombosis.117 There is evidence of low certainty sup-
porting the occurrence of intra-arrest thrombolysis in patients 
suspected with PTE.118-120 There is also evidence of very low cer-
tainty supporting the performance of surgical embolization or 
percutaneous mechanical thrombectomy to resuscitate patients 
with cardiac arrest.121 Therefore, thrombolysis is recommended in 
cardiac arrest patients suspected of PTE. Providers should also 
consider performing surgical embolectomy or percutaneous me-
chanical embolectomy in cardiac arrest patients diagnosed with 
PTE.
Cardiac arrest in pregnancy
In pregnant women over 20 weeks of gestation, the cardiac out-
put might be decreased by 30% to 40% as a result of compres-
sion of the inferior vena cava and aorta by the uterus, which re-
duces venous return.122 In this case, the effectiveness of chest 
compressions may be reduced. The easiest method to avoid com-
pressing the inferior vena cava or aorta is by lateral uterine dis-
placement, which can be achieved by placing the patient in a su-
pine position on a firm surface and moving the uterus to the pa-
tient’s left by pushing it with one hand from the right side or pull-
ing it with two hands from the left side.123,124
 When providing chest compressions, the provider may consid-
er placing the chest compressions slightly higher than the center 
of the sternum, which is the standard position, to take account 
of the rise of the abdominal cavity and diaphragm during preg-
nancy.125,126 However, there is still insufficient evidence about the 
proper positioning of chest compressions in pregnancy. Since 
there is no change in transthoracic impedance during pregnancy 
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and there are no reports that defibrillation affects the fetal heart, 
defibrillation can be performed according to standard CPR gui-
delines.
 If cardiac arrest is imminent or occurs in pregnant women, hys-
terotomy or cesarean section should be performed as soon as 
possible. Early delivery can improve the resuscitation outcomes 
by relieving compression of the aorta and vena cava.127 Several 
studies of pregnant women with cardiac arrest showed that fetal 
survival rates were high when the cesarean section was per-
formed successfully within 5 minutes of cardiac arrest.128 There-
fore, it is recommended to perform a cesarean section within 5 
minutes when spontaneous circulation is not achieved even after 
performing CPR for the first 4 minutes in pregnant women who 
are at >20 weeks of gestation or whose uterus is palpable above 
the umbilicus.
RRT and early warning score in IHCA
“Early recognition and CPR team activation” constitute the first 
chain of survival from IHCA according to the 2000 Korean CPR 
guidelines. For successful resuscitation of patients with IHCA, an 
appropriate survival environment that includes operation of an 
RRT, training in ALS, establishment of a cardiac arrest treatment 
system, and quality improvement activities must be established.129-131
 An RRT is designed to detect patients who are deteriorating rap-
idly at an early stage and to respond appropriately.13 The role of 
an RRT includes making decisions about transferring the patient 
to the intensive care unit, implementing a do-not-resuscitate or-
der, performing intensive care including CPR, and planning care 
for a patient with terminal illness.
 Most cases of IHCA exhibit a non-shockable rhythm at an ear-
ly stage, which is generally preceded by respiratory failure or 
shock.81,132,133 Therefore, the use of an early warning score can 
help the RRT detect a rapidly deteriorating patient. Hospital sys-
tems may use different early warning scores, but the NEWS (Na-
tional Early Warning Score) and MEWS (Modified Early Warning 
Score) are well known.17
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